Jonathan Said

32.1k total citations · 6 hit papers
370 papers, 20.5k citations indexed

About

Jonathan Said is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jonathan Said has authored 370 papers receiving a total of 20.5k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Oncology, 123 papers in Molecular Biology and 111 papers in Pathology and Forensic Medicine. Recurrent topics in Jonathan Said's work include Lymphoma Diagnosis and Treatment (88 papers), Viral-associated cancers and disorders (58 papers) and Renal cell carcinoma treatment (55 papers). Jonathan Said is often cited by papers focused on Lymphoma Diagnosis and Treatment (88 papers), Viral-associated cancers and disorders (58 papers) and Renal cell carcinoma treatment (55 papers). Jonathan Said collaborates with scholars based in United States, Singapore and Japan. Jonathan Said's co-authors include H. Phillip Koeffler, Ethel Cesarman, Daniel M. Knowles, Patrick S. Moore, Yuan Chang, Arie S. Belldegrun, Allan J. Pantuck, Geraldine S. Pinkus, Amnon Zisman and Robert A. Figlin and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jonathan Said

365 papers receiving 20.0k citations

Hit Papers

Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequence... 1995 2026 2005 2015 1995 1998 2001 1998 1998 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
    1995 2.3k citations Jonathan Said et al. profile →
  2. Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
    1998 719 citations Peter Shintaku, Jonathan Said et al. profile →
  3. Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
    2001 542 citations Allan J. Pantuck, Jonathan Said et al. Journal of Clinical Oncology profile →
  4. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    1998 534 citations Jonathan Said, H. Phillip Koeffler et al. profile →
  5. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
    1998 526 citations Jonathan Said et al. profile →
  6. Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma
    2002 501 citations Allan J. Pantuck, Jonathan Said et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Said United States 73 8.5k 8.2k 5.2k 4.5k 3.5k 370 20.5k
Bernd Dörken Germany 81 8.6k 1.0× 8.6k 1.0× 2.3k 0.4× 4.8k 1.1× 3.1k 0.9× 412 22.0k
Luigi Terracciano Switzerland 86 9.2k 1.1× 8.7k 1.1× 4.3k 0.8× 3.0k 0.7× 4.4k 1.3× 565 26.2k
Giampaolo Tortora Italy 69 9.9k 1.2× 13.8k 1.7× 7.8k 1.5× 1.7k 0.4× 4.8k 1.4× 639 24.4k
Julie Teruya‐Feldstein United States 77 13.1k 1.5× 7.6k 0.9× 1.7k 0.3× 4.2k 0.9× 5.5k 1.6× 216 22.2k
Jennifer R. Grandis United States 75 10.6k 1.3× 10.5k 1.3× 5.0k 1.0× 1.7k 0.4× 4.1k 1.2× 342 23.4k
Pierre Laurent‐Puig France 86 10.9k 1.3× 17.0k 2.1× 7.1k 1.4× 9.5k 2.1× 8.5k 2.4× 540 34.6k
Richard Greil Austria 67 5.3k 0.6× 10.9k 1.3× 4.1k 0.8× 4.2k 0.9× 3.9k 1.1× 731 20.1k
M. Kay Washington United States 78 8.4k 1.0× 6.5k 0.8× 2.9k 0.6× 1.7k 0.4× 3.3k 1.0× 360 21.1k
Ivan Bièche France 76 11.1k 1.3× 5.9k 0.7× 2.6k 0.5× 1.7k 0.4× 5.7k 1.6× 497 20.2k
Maria Tsokos United States 69 5.3k 0.6× 3.7k 0.4× 3.5k 0.7× 1.5k 0.3× 1.4k 0.4× 244 15.2k

Countries citing papers authored by Jonathan Said

Since Specialization
Citations

This map shows the geographic impact of Jonathan Said's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Said with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Said more than expected).

Fields of papers citing papers by Jonathan Said

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Said. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Said. The network helps show where Jonathan Said may publish in the future.

Co-authorship network of co-authors of Jonathan Said

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Said. A scholar is included among the top collaborators of Jonathan Said based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Said. Jonathan Said is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oh, Angela, Connie M. Sears, Brigitte N. Gomperts, et al.. (2024). Orbital indeterminate cell histiocytosis. Orbit. 44(1). 96–100.
2.
Sun, Haibo, De‐Chen Lin, Qi Cao, et al.. (2017). Identification of a Novel SYK/c-MYC/MALAT1 Signaling Pathway and Its Potential Therapeutic Value in Ewing Sarcoma. Clinical Cancer Research. 23(15). 4376–4387. 48 indexed citations
3.
Lin, De‐Chen, Liang Xu, Ye Chen, et al.. (2015). Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma. Cancer Research. 75(9). 1815–1827. 51 indexed citations
4.
Ding, Ling‐Wen, Qiao‐Yang Sun, Wenwen Chien, et al.. (2014). LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene. 34(11). 1463–1474. 20 indexed citations
5.
Su, Albert, Sarah Dry, Scott W. Binder, et al.. (2013). Malignant Melanoma With Neural Differentiation. American Journal of Dermatopathology. 36(1). e5–e9. 15 indexed citations
6.
Wang, Piwen, Jaydutt V. Vadgama, Jonathan Said, et al.. (2013). Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. The Journal of Nutritional Biochemistry. 25(1). 73–80. 64 indexed citations
7.
Zhou, Yan, Conghui Zhao, Sigal Gery, et al.. (2013). Off-Target Effects of c-MET Inhibitors on Thyroid Cancer Cells. Molecular Cancer Therapeutics. 13(1). 134–143. 25 indexed citations
8.
Yin, Dong, Seishi Ogawa, Norihiko Kawamata, et al.. (2012). miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene. 32(9). 1155–1163. 95 indexed citations
9.
Aronson, William J., Naoko Kobayashi, R. James Barnard, et al.. (2011). Phase II Prospective Randomized Trial of a Low-Fat Diet with Fish Oil Supplementation in Men Undergoing Radical Prostatectomy. Cancer Prevention Research. 4(12). 2062–2071. 61 indexed citations
10.
Mehta, Hemal H., Qinglei Gao, Colette Galet, et al.. (2011). IGFBP-3 Is a Metastasis Suppression Gene in Prostate Cancer. Cancer Research. 71(15). 5154–5163. 78 indexed citations
11.
Andorsky, David, Reiko Yamada, Jonathan Said, et al.. (2011). Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells. Clinical Cancer Research. 17(13). 4232–4244. 267 indexed citations
12.
Widney, Daniel P., Dorina Gui, Laura M. Popoviciu, et al.. (2010). Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma. AIDS Research and Treatment. 2010. 1–9. 30 indexed citations
13.
Thoennissen, Nils H., Gabriela B. Iwanski, Ngan Doan, et al.. (2009). Cucurbitacin B Induces Apoptosis by Inhibition of the JAK/STAT Pathway and Potentiates Antiproliferative Effects of Gemcitabine on Pancreatic Cancer Cells. Cancer Research. 69(14). 5876–5884. 203 indexed citations
14.
Klatte, Tobias, Priya Rao, Michela de Martino, et al.. (2009). Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma. Journal of Clinical Oncology. 27(5). 746–753. 151 indexed citations
15.
Kobayashi, Naoko, R. James Barnard, Jonathan Said, et al.. (2008). Effect of Low-Fat Diet on Development of Prostate Cancer and Akt Phosphorylation in the Hi-Myc Transgenic Mouse Model. Cancer Research. 68(8). 3066–3073. 64 indexed citations
16.
Pullarkat, Sheeja T., et al.. (2007). Systemic mastocytosis with plasma cell dyscrasia: Report of a case. Leukemia Research. 32(7). 1160–1163. 11 indexed citations
17.
Kobayashi, Naoko, R. James Barnard, Susanne M. Henning, et al.. (2006). Effect of Altering Dietary ω-6/ω-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2. Clinical Cancer Research. 12(15). 4662–4670. 131 indexed citations
18.
Takai, Noriyuki, Anjali Jain, Norihiko Kawamata, et al.. (2005). 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth. Cancer. 104(12). 2701–2708. 62 indexed citations
19.
Hoyer, Katrina K., Mabel Pang, Dorina Gui, et al.. (2004). An Anti-Apoptotic Role for Galectin-3 in Diffuse Large B-Cell Lymphomas. American Journal Of Pathology. 164(3). 893–902. 100 indexed citations
20.
Hatta, Yoshihiro, Konstantin S. Spirin, Taizo Tasaka, et al.. (1997). Analysis of p18INK4C in adult T‐cell leukaemia and non‐Hodgkin's lymphoma. British Journal of Haematology. 99(3). 668–670. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernd Dörken Breakdown of academic impact, for papers by Luigi Terracciano Breakdown of academic impact, for papers by Giampaolo Tortora Breakdown of academic impact, for papers by Julie Teruya‐Feldstein Breakdown of academic impact, for papers by Jennifer R. Grandis Breakdown of academic impact, for papers by Pierre Laurent‐Puig Breakdown of academic impact, for papers by Richard Greil Breakdown of academic impact, for papers by M. Kay Washington Breakdown of academic impact, for papers by Ivan Bièche Breakdown of academic impact, for papers by Maria Tsokos
Rankless by CCL
2026